Pediatric Diabetes Clinical Trials
By Eugenia Yun
Clinical researchers are working to discover newer strategies and medications to help children with diabetes live healthier, happier lives. Here are some exciting clinical trials your child might be able to join now.
Managing diabetes in children can be challenging for many reasons, from difficulties and discomfort due to insulin injections to monitoring for potential diabetes-related complications, not to mention parents’ worries about the safety of various medications. The good news is that researchers are continually working to find better ways to help children with type 1 or type 2 diabetes live more comfortable, healthier lives. Here are several trials looking to enroll children and adolescents with diabetes.
1. Inhaled Insulin for Children With Diabetes
A U.S. clinical trial sponsored by Mannkind Corporation is recruiting children with type 1 or type 2 diabetes to evaluate the effectiveness and safety of the long-term use of Afrezza, an inhaled insulin. A safe and effective inhaled insulin would be an exciting option for families who wish to lessen the number of injections given per day.
2. Can a Twice-Daily Pill Protect Beta-Cell Function?
Adolescents and adults newly diagnosed with type 1 diabetes may be eligible to participate in a study evaluating the effectiveness of ladarixin, a treatment that may preserve beta-cell function and delay the progression of type 1 diabetes.
3. SGLT2 Inhibitors for Teens With Type 1 Diabetes
A U.S. clinical trial sponsored by The Hospital for Sick Children is recruiting teens with type 1 diabetes to participate in a study evaluating the effect of dapagliflozin, an SGLT2 inhibitor, on kidney function. SGLT2 inhibitors have been shown to protect the kidneys in adults with type 2 diabetes, but they are not currently FDA-approved for people with type 1 diabetes.
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)
This study aims to evaluate the safety and efficacy of tirzepatide in children and teens with type 2 diabetes who are taking metformin, insulin, or both.
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
This study aims to evaluate the safety and efficacy of ertugliflozin in children with type 2 diabetes taking metformin with or without insulin.
Diamyd Administered Into Lymph Nodes in Individuals Recently Diagnosed With Type 1 Diabetes, Carrying the HLA DR3-DQ2 Haplotype (DIAGNODE-3)
This study aims to evaluate the safety and efficacy of injections of Diamyd to the lymph nodes to preserve beta-cell function in adolescents and adults recently diagnosed with type 1 diabetes.
Surgical or Medical Treatment (ST2OMP)
This study aims to evaluate the effect of bariatric surgery on blood glucose management and related conditions in teens with type 2 diabetes and obesity.